217 related articles for article (PubMed ID: 396064)
1. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Ibsen H; Leth A; McNair A; Giese J
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II blockade during combined thiazide-beta-blocker treatment.
Ibsen H; Leth A; McNair A; Christensen NJ; Giese J
Scand J Clin Lab Invest; 1980 Jun; 40(4):325-31. PubMed ID: 6106282
[TBL] [Abstract][Full Text] [Related]
3. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
Pettinger WA; Mitchell HC
N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Van Hoogdalem P; Donker AJ; Leenen FH
Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system and the antihypertensive effect of atenolol in man.
Mimran A; Deschodt G; Fourcade J; Barjon P
Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):100-7. PubMed ID: 526065
[TBL] [Abstract][Full Text] [Related]
6. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
7. Effects of metoprolol on blood pressure and plasma renin activity in thiazide-resistant hypertensive patients.
Velasquez MT; Han Wan S; Maronde RF
Clin Pharmacol Ther; 1979 Nov; 26(5):555-61. PubMed ID: 498696
[TBL] [Abstract][Full Text] [Related]
8. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
[TBL] [Abstract][Full Text] [Related]
9. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Laragh JH; Case DB; Wallace JM; Keim H
Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
11. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
McGrath BP; Ledingham JG; Benedict CR
Clin Sci Mol Med; 1977 Oct; 53(4):341-8. PubMed ID: 913058
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Christensen NJ; Giese J
Acta Med Scand; 1979; 205(7):547-55. PubMed ID: 474180
[No Abstract] [Full Text] [Related]
13. Diuretics, beta-blockers or both as treatment for essential hypertension.
Stumpe KO; Overlack O
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
[TBL] [Abstract][Full Text] [Related]
15. Diuretic therapy and response of essential hypertension to saralasin.
Anderson GH; Dalakos TG; Elias A; Tomycz N; Streeten DH
Ann Intern Med; 1977 Aug; 87(2):183-7. PubMed ID: 889199
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II blockade by saralasin in normal man.
Noth RH; Tan SY; Mulrow PJ
J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
[TBL] [Abstract][Full Text] [Related]
18. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
19. Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol.
Geyskes GG; Boer P; Vos J; Dorhout Mees EJ
Lancet; 1976 May; 1(7968):1049-51. PubMed ID: 57453
[TBL] [Abstract][Full Text] [Related]
20. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
